Main Menu
Home
Events
Publications
Audio / Video
Capability checklists
Fact Sheets
Presentations
Papers / Reports
Roundups
 

Document details

Guideline: Management Acute Behavioural Disturbance due to Amphetamine-Type Stimulant intoxication
Details for Guideline: Management Acute Behavioural Disturbance due to Amphetamine-Type Stimulant intoxication
PropertyValue
NameGuideline: Management Acute Behavioural Disturbance due to Amphetamine-Type Stimulant intoxication
Description

Guideline for the management of Acute Behavioural Disturbance due to Amphetamine-Type Stimulant intoxication

- Oct 2014 version
New, 4-page guideline developed by VDDI-NEXUS Consultant Psychiatrist Dr Kah Seong-Loke . Dr Loke profiled the new guideline in a recent presentation to the 2014 Australian Drugs Conference Ice & Altered Realities: Amphetamine Intoxication Withdrawal - Management Guidelines for Acute Hospital Settings

Page 1 of the Guideline provides guidelines for acute assessment and management of ATS intoxication and toxicity (see explanation in slides 18-22 of the conference presentation)


Page 2 of the Guideline provides guidelines for the management of acute behavioural disturbance due to ATS intoxication  (see explanation in slides 23-37 of the conference presentation). Here Dr Loke profiles detailed suggested regimes from:
- Management of Patients with Psychostimulant Toxicity: Guidelines for Emergency Departments DoHA 2006 

- Management of Acute Amphetamine Related Problems (DAO WA, 2006) (not available online but medication regime summarised p19 in Turning Point’s Methamphetamine dependence and treatment 2007 guideline

- Guidelines for the medical management of patients with methamphetamine-induced psychosis DASSA 2006 (Abbreviated 2-page guideline here )

- Management of acute agitation in psychosis: an evidence-based approach in the USA. Schleifer, J. 2011 Advances in psychiatric treatment. 

- The psychopharmacology of agitation: Consensus statement of the American Association for Emergency Psychiatry Project BETA 2012)

N.B.: Note, in step 3 of page 2, that use of Midazolam is mentioned and alert below that cautioning that 'IM Midazolam should only ever be prescribed by a consultant and special precautions MUST be followed’. Local policies will provide further guidance re use of Midazolam

 Page 3 of the Guideline suggests interventions matched to the client’s stage of change

• Page 4 of the Guideline provides guidelines for the long-term management of amphetamine misuse and dependence (BI’s., supported withdrawal etc - see explanation in slides 39-46 of the conference presentation)

GC

Filesize574.83 KB
Filetypepdf  (Mime Typeapplication/pdf)
Created On: 13.02.2015 13:41
ViewersEverybody
Hits3649Hits
Last updated on 13.02.2015 14:41

Linked sites

Dual Diagnosis Support

DualDiagnosisANZ_YouTube

DualDiagnosisANZ on Twitter

DualDiagnosisANZ on Facebook

 

Eastern Hume Dual Diagnosis Service Dual Diagnosis Australia & New Zealand is a project of
Eastern Hume Dual Diagnosis Service
Mental Health Services, Northeast Health, Wangaratta
Northeast Health Wangaratta